KELES

Alexandre Ziad Karkour is a strategic advisor specializing in cross-border M&A, private equity, and venture capital, with a track record in tech, financial services, and healthcare. As Venture Partner, Alex will support KELES in fundraising, building dealflow and investment decisions. Alex began his career at Reed Elsevier in Paris before joining SmithKline Beecham in London,…

Mike Zurawski joined KELES in December 2024 as Investment Partner and is based in London (UK). He is part of the KELES investment committee, works with the investment team building and reviewing dealflow as well as supporting portfolio companies on their growth trajectory and establishing strategic partnerships throughout the ecosystem. Mike is driven by a…

Paris & London – March 24, 2025: PwC and KELES, the pioneering digital health venture capital (VC) firm, are setting a new standard in digital health investment, leveraging ESG and innovation. With its novel, forward-thinking Sustainable Finance Disclosure Regulation (SFDR) Article 9 ESG framework, certified by PwC, KELES is leading the charge in shaping the…

Pooja Majmudar is a Ph. D in molecular biology, seasoned healthcare and life sciences executive, digital health investment professional and well recognized thought leader. Pooja is known for her extensive network across the healthcare venture capital and startup ecosystem in the US and strong track record bridging groundbreaking research to enabling real market success. As…

Paris & London – 3rd December, 2024 : KELES, venture capital firm led by digital health investors David Buller and Laurent Van Lerberghe, appoints three expert advisors to strengthen its leadership team and accelerate progress in European digital health innovation. Continuing momentum from the fund’s launch on 8th October 2024, KELES is joined by experienced…